Distinct biological impact of dephosphorylation vs. downregulation of p210Bcr-Abl: implications for imatinib mesylate response and resistance.

Source:http://linkedlifedata.com/resource/pubmed/id/16966279

Download in:

View as

General Info

PMID
16966279